MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene

doi:10.1186/1471-2350-8-81

BMC Medical Genetics

Volume 8

Viewing options:

Abstract
Full text
PDF (459KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Ballana E
Mercader JM
Fischel-Ghodsian N
Estivill X

on PubMed

Ballana E
Mercader JM
Fischel-Ghodsian N
Estivill X
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research article

MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene

Ester Ballana¹ , Josep Maria Mercader¹^,2 , Nathan Fischel-Ghodsian³ and Xavier Estivill¹^,2^,4^,5

¹Genes and Disease Program, Centre for Genomic Regulation (CRG), Barcelona, Catalonia, Spain

²CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Catalonia, Spain

³Cedars-Sinai Medical Center and David Geffen School of Medicine at UCLA, Los Angeles, USA

⁴CeGen, Spanish National Genotyping Centre, Barcelona, Catalonia, Spain

⁵Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain

author email corresponding author email

BMC Medical Genetics 2007, 8:81doi:10.1186/1471-2350-8-81


Published:	21 December 2007

Abstract

Background

Mitochondrial DNA (mtDNA) mutations account for at least 5% of cases of postlingual, nonsyndromic hearing impairment. Among them, mutation A1555G is frequently found associated with aminoglycoside-induced and/or nonsyndromic hearing loss in families presenting with extremely variable clinical phenotypes. Biochemical and genetic data have suggested that nuclear background is the main factor involved in modulating the phenotypic expression of mutation A1555G. However, although a major nuclear modifying locus was located on chromosome 8p23.1 and regardless intensive screening of the region, the gene involved has not been identified.

Methods

With the aim to gain insights into the factors that determine the phenotypic expression of A1555G mutation, we have analysed in detail different genetic and genomic elements on 8p23.1 region (DEFA3 gene absence, CLDN23 gene and MRPS18CP2 pseudogene) in a group of 213 A1555G carriers.

Results

Family based association studies identified a positive association for a polymorphism on MRPS18CP2 and an overrepresentation of DEFA3 gene absence in the deaf group of A1555G carriers.

Conclusion

Although none of the factors analysed seem to have a major contribution to the phenotype, our findings provide further evidences of the involvement of 8p23.1 region as a modifying locus for A1555G 12S rRNA gene mutation.